// App-Quantinova.ai

: Assessment of clotting activity of recombinant fix FC fusion protein in European hemophilia treatment centers

Researchers

Presenter

  • A. Willemze

Principal Investigators

  • A. Sadeghi-Khomami

  • L. Srskog

  • M. Wikn

  • S. Lethagen

Medical Centers

  • Swedish Orphan Biovitrum AB, Stockholm, Sweden

  • Precision BioLogic Inc., Dartmouth, Nova Scotia, Canada

  • BRIC, Copenhagen University, Copenhagen, Denmark

Locations

  • Sweden

  • Canada

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Alprolix Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Swedish Orphan Biovitrum

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved